| 000 | 00833naa a22002417a 4500 | ||
|---|---|---|---|
| 001 | 216206 | ||
| 035 | _a(OCoLC)1365238632 | ||
| 999 |
_c216206 _d216206 |
||
| 003 | ES-MaBCM | ||
| 005 | 20240706062600.0 | ||
| 008 | 201124t2020 sp ||||| |||| 00| 0 spa d | ||
| 040 | _cES-MaBCM | ||
| 245 | 0 | 3 | _aLa Sanidad Pública tras la pandemia |
| 650 | 7 |
_aEpidemia _2 _958578 |
|
| 650 | 7 |
_aSistema sanitario _2 _991034 |
|
| 650 | 7 |
_aSalud pública _2 _960170 |
|
| 650 | 7 |
_aProfesión sanitaria _2 _959927 |
|
| 650 | 7 |
_aPersonal sanitario _2 _958555 |
|
| 650 | 7 |
_aEstablecimiento farmacéutico _2 _958688 |
|
| 651 | 4 |
_aEspaña _9115342 |
|
| 773 | 0 |
_dMadrid _gn. 311 (nov.- 2020), 48 p. - Loc. S.242.1 _tTemas para el debate _w105072 |
|
| 856 |
_uhttp://mpr.orex.es/cgi-bin/koha/opac-retrieve-file.pl?id=c6b933a12bbd0520ec182591f03e9817 _yAcceso al sumario |
||
| 942 |
_2udc _cAREV |
||